Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Casey

Showing results (41-50 of 312) with videos related to

Pageof 32
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2004
Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressivenessMine S Cicek, Nora L Nock, Li Li, et al.
The Prostate|October 18, 2006
Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family historyEric Jorgenson, Steven R Deitcher, Mine Cicek, et al.
Human Heredity|April 19, 2013
Incorporating prior biologic information for high-dimensional rare variant association studiesMelanie A Quintana, Fredrick R Schumacher, Graham Casey, et al.
Clinical & Experimental Metastasis|January 24, 2009
BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoterMuzaffer Cicek, Ryuichi Fukuyama, Mine S Cicek, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 25, 2003
CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancerSarah J Plummer, David V Conti, Pamela L Paris, et al.
European Journal of Human Genetics : EJHG|January 31, 2008
8q24 and prostate cancer: association with advanced disease and meta-analysisIona Cheng, Sarah J Plummer, Eric Jorgenson, et al.
Statistical Science : a Review Journal of the Institute of Mathematical Statistics|July 8, 2010
Methodological Issues in Multistage Genome-wide Association StudiesDuncan C Thomas, Graham Casey, David V Conti, et al.
World Journal of Gastroenterology|May 14, 2009
No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer riskCheryl-L Thompson, Sarah-J Plummer, Alona Merkulova, et al.
The Prostate|October 15, 2010
Fine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35Xin Liu, Iona Cheng, Sarah J Plummer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2008
A common 8q24 variant and the risk of colon cancer: a population-based case-control studyLi Li, Sarah J Plummer, Cheryl L Thompson, et al.
Pageof 32

Showing results (41-50 of 312) with videos related to

Sort By:
Pageof 32
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2004
Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressivenessMine S Cicek, Nora L Nock, Li Li, et al.
The Prostate|October 18, 2006
Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family historyEric Jorgenson, Steven R Deitcher, Mine Cicek, et al.
Human Heredity|April 19, 2013
Incorporating prior biologic information for high-dimensional rare variant association studiesMelanie A Quintana, Fredrick R Schumacher, Graham Casey, et al.
Clinical & Experimental Metastasis|January 24, 2009
BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoterMuzaffer Cicek, Ryuichi Fukuyama, Mine S Cicek, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 25, 2003
CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancerSarah J Plummer, David V Conti, Pamela L Paris, et al.
European Journal of Human Genetics : EJHG|January 31, 2008
8q24 and prostate cancer: association with advanced disease and meta-analysisIona Cheng, Sarah J Plummer, Eric Jorgenson, et al.
Statistical Science : a Review Journal of the Institute of Mathematical Statistics|July 8, 2010
Methodological Issues in Multistage Genome-wide Association StudiesDuncan C Thomas, Graham Casey, David V Conti, et al.
World Journal of Gastroenterology|May 14, 2009
No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer riskCheryl-L Thompson, Sarah-J Plummer, Alona Merkulova, et al.
The Prostate|October 15, 2010
Fine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35Xin Liu, Iona Cheng, Sarah J Plummer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2008
A common 8q24 variant and the risk of colon cancer: a population-based case-control studyLi Li, Sarah J Plummer, Cheryl L Thompson, et al.
Pageof 32